Home/Gamma Diagnostics/Chris Venter

CV

Chris Venter

CEO

Gamma Diagnostics

Therapeutic Areas

Cardiovascular Disease Infectious Disease Inflammatory Conditions

Gamma Diagnostics Pipeline

Drug	Indication	Phase
GammaCoeur GPF Test	Cardiovascular Disease Risk Assessment (Heart Attack, Stroke)	Commercial
GPF Test for Inflammatory Diseases	COVID-19 Severity Prediction	Research/Validation

Leadership Team at Gamma Diagnostics

Dr. David Farrell

Founder and Chief Scientific Officer (CSO)

Gerry Mabarrack

Head of Business Development

View full Gamma Diagnostics profile